Rehovot, Israel — September 2, 2025 — Leads & Copy — BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0) will host a virtual investor webinar on Wednesday, September 10, 2025, at 1:00 p.m. Eastern time. CEO Ilan Sobel will host the webinar to provide a corporate update on new capability-building initiatives and the company’s ‘Big Bets’ for 2H 2025, followed by a Q&A session.
To attend, dial 1-877-300-8521 (U.S./Canada) or 1-412-317-6026 (International) with Conference ID: 10202632, or visit the BHST Virtual Investor Webinar webcast link. A telephone playback will be available through September 24, 2025, at 1-844-512-2921 (U.S./Canada) or 1-412-317-6671 (International), using replay pin number 10202632. A webcast replay will also be available.
Sobel said the webinar offers a chance to discuss new developments across consumer and CDMO business units and provide updates on ‘Big Bets’ like the Health Pros program, hydration product, and key CDMO efforts, while exploring new technology initiatives. The company remains focused on profitable growth and delivering long-term value.
BioHarvest Sciences Inc. is a leader in Botanical Synthesis, using its patented technology to grow active plant ingredients without growing the plant. It develops therapeutic solutions within two business verticals: a contract development and production organization (CDMO) and proprietary nutraceutical health and wellness products.
Dave Ryan, VP Investor Relations, (604) 622-1186, info@bioharvest.com
Lucas A. Zimmerman, Managing Director, MZ Group – MZ North America, (949) 259-4987, BHST@mzgroup.us
Source: BioHarvest Sciences Inc.
